Implications Of A Prognostic 40-Gene Expression Profile (40-Gep) Test For High-Risk Cutaneous Squamous Cell Carcinoma (Cscc) On Staging-Based Risk Assessment And Adjuvant Therapy Trial Design.
JOURNAL OF CLINICAL ONCOLOGY（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要